SNTI - Senti Biosciences, Inc.
1.01
-0.130 -12.871%
Share volume: 262,125
Last Updated: 04-23-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.14
-0.13
-0.11%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-14-2024 | 03-20-2025 | 05-06-2025 | 11-13-2025 | 03-27-2026 | |
| Cash flow financing | 0.000 | 0.000 | 2.440 M | 51.290 M | -414.000 K | 124.000 K | 11.040 M | |
| Other financing cash flows | 0.000 | 0.000 | 2.430 M | 2.470 M | 1.510 M | 0.000 | 530.000 K | |
| Cash flow | -11.682 M | 0.000 | -5.366 M | 37.775 M | -14.464 M | 0.000 | 0.000 | |
| Net income | -12.111 M | -11.203 M | -28.866 M | -610.000 K | -14.112 M | -18.126 M | -14.467 M | |
| Depreciation | 1.461 M | 971.000 K | 946.000 K | 937.000 K | 926.000 K | 904.000 K | 893.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 17.923 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -15.000 K | 0.000 | 60.000 K | -11.000 K | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | -1.020 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -15.000 K | 0.000 | 0.000 | 11.000 K | 0.000 | 0.000 | 0.000 | |
| Cash Change | 23.723 M | -8.345 M | -5.366 M | 37.775 M | -14.464 M | -9.322 M | 4.165 M |